Wolfson A B, Yealy D M
Center for Emergency Medicine, Pittsburgh, PA 15213.
Am J Emerg Med. 1991 Jan;9(1):16-9. doi: 10.1016/0735-6757(91)90005-5.
A number of studies have suggested that nonsteroidal antiinflammatory agents can relieve renal colic by a mechanism of action different from that of narcotics, offering the potential advantage of avoiding narcotic side-effects such as alteration of mental status. The authors prospectively administered oral indomethacin, 50 mg, to 25 nonvomiting patients with acute renal colic due to a documented stone. Eleven patients group (I) received the drug in an unblinded, nonrandomized fashion after failure of oral or parenteral narcotics to provide satisfactory pain relief, either at home or in the emergency department. In 14 additional patients group (II) indomethacin was given as the only initial treatment. Pain intensity before and after treatment was reported using a 1-to-10 scale. In group I, pain decreased from 5.8 +/- 2.7 to 3.6 +/- 3.8 (P less than .02). Six of the 11 patients reported a decrease in pain intensity of 50% or more, which occurred within 25 +/- 11 minutes, and in 5 of these 6, pain decreased to a 0 or 1 level. In group II, pain decreased from 7.6 +/- 1.5 to 4.6 +/- 4.0 (P less than .008). Eight of the 14 patients reported a decrease in pain intensity of 50% or more, which occurred within 40 +/- 14 minutes, and in 5 of these 8 pain decreased to a 0 or 1 level. Among all 25 patients who received indomethacin, pain relief was not significantly associated with the duration of pain before treatment or with patient age or sex. There was a trend for pretreatment pain intensity to be higher among nonresponders (P = .07).(ABSTRACT TRUNCATED AT 250 WORDS)
多项研究表明,非甾体类抗炎药可通过与麻醉药不同的作用机制缓解肾绞痛,具有避免麻醉药副作用(如精神状态改变)的潜在优势。作者前瞻性地对25例因证实有结石而患急性肾绞痛的无呕吐患者口服50毫克消炎痛。11例患者组(I)在口服或胃肠外使用麻醉药未能在家中或急诊科提供满意的疼痛缓解后,以非盲法、非随机方式接受该药治疗。另外14例患者组(II)将消炎痛作为唯一的初始治疗。使用1至10分制报告治疗前后的疼痛强度。在I组中,疼痛从5.8±2.7降至3.6±3.8(P<0.02)。11例患者中有6例报告疼痛强度降低了50%或更多,这发生在25±11分钟内,在这6例中的5例中,疼痛降至0或1级。在II组中,疼痛从7.6±1.5降至4.6±4.0(P<0.008)。14例患者中有8例报告疼痛强度降低了50%或更多,这发生在40±14分钟内,在这8例中的5例中,疼痛降至0或1级。在所有25例接受消炎痛治疗的患者中,疼痛缓解与治疗前疼痛持续时间、患者年龄或性别无显著相关性。无反应者的治疗前疼痛强度有升高趋势(P = 0.07)。(摘要截短至250字)